Lucid Diagnostics (LUCD) News Today $1.15 -0.08 (-6.50%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$1.14 -0.01 (-0.87%) As of 10/10/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUCD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Ascendiant Capital Markets Increases Lucid Diagnostics (NASDAQ:LUCD) Price Target to $8.00October 8, 2025 | americanbankingnews.comAscendiant Capital Maintains Lucid Diagnostics (LUCD) Buy RecommendationOctober 6, 2025 | msn.comLucid Diagnostics (NASDAQ:LUCD) Price Target Raised to $8.00October 6, 2025 | marketbeat.comLucid Diagnostics (NASDAQ:LUCD) Lowered to "Sell" Rating by Wall Street ZenOctober 6, 2025 | marketbeat.comBrokerages Set Lucid Diagnostics Inc. (NASDAQ:LUCD) Target Price at $3.65October 3, 2025 | americanbankingnews.comLucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Recommendation of "Buy" by AnalystsSeptember 30, 2025 | marketbeat.comLucid Diagnostics: Holding Onto Medicare Coverage HopesSeptember 29, 2025 | seekingalpha.comLucid Diagnostics (NASDAQ:LUCD) Rating Increased to Hold at Wall Street ZenSeptember 28, 2025 | marketbeat.comLucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of DirectorsSeptember 25, 2025 | prnewswire.comLucid Diagnostics (NASDAQ:LUCD) Cut to Sell at Wall Street ZenSeptember 20, 2025 | marketbeat.comLucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government AffairsSeptember 16, 2025 | prnewswire.comLucid Diagnostics Announces Public Stock OfferingSeptember 12, 2025 | msn.comLucid Diagnostics Completes Public Offering for $26.9 MillionSeptember 11, 2025 | tipranks.comLucid Diagnostics Announces Closing of Public Offering of Common StockSeptember 11, 2025 | prnewswire.comLucid Prices Public Share OfferingSeptember 11, 2025 | baystreet.caLucid Diagnostics Announces Pricing of Public Offering of Common StockSeptember 10, 2025 | prnewswire.comLucid Diagnostics Announces Proposed Public Offering of Common StockSeptember 9, 2025 | prnewswire.comLucid Diagnostics Inc. (LUCD) Investor Conference Call (Transcript)September 8, 2025 | seekingalpha.comAlyeska Investment Group L.P. Invests $2.81 Million in Lucid Diagnostics Inc. $LUCDSeptember 8, 2025 | marketbeat.comLucid Diagnostics price target raised to $2.50 from $2 at BTIGSeptember 5, 2025 | msn.comLucid Diagnostics to Host Investor Call on Monday, September 8, 2025September 5, 2025 | prnewswire.comGhisallo Capital Management LLC Takes $629,000 Position in Lucid Diagnostics Inc. $LUCDSeptember 2, 2025 | marketbeat.comCanaccord Genuity Remains a Buy on Lucid Diagnostics (LUCD)August 29, 2025 | theglobeandmail.comLucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025August 27, 2025 | prnewswire.comPAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging TechnologyAugust 26, 2025 | prnewswire.comInsider Buying: Lucid Diagnostics (NASDAQ:LUCD) Director Acquires 100,000 Shares of StockAugust 23, 2025 | insidertrades.comLucid Diagnostics (LUCD) Gets a Buy from BTIGAugust 22, 2025 | theglobeandmail.comLucid Diagnostics (NASDAQ:LUCD) Raised to "Hold" at Wall Street ZenAugust 17, 2025 | marketbeat.comNeedham & Company LLC Reaffirms "Buy" Rating for Lucid Diagnostics (NASDAQ:LUCD)August 15, 2025 | marketbeat.comLucid Diagnostics reports Q2 non-GAAP EPS (10c), consensus (10c)August 15, 2025 | msn.comPAVmed Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 14, 2025 | prnewswire.comLucid Diagnostics Advances Towards Medicare CoverageAugust 14, 2025 | msn.comLucid Diagnostics Inc (LUCD) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic ...August 14, 2025 | finance.yahoo.comLucid Diagnostics Reports Q2 2025 EarningsAugust 13, 2025 | tipranks.comLucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comLucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 13, 2025 | prnewswire.comWhat To Expect From Lucid Diagnostics Inc (LUCD) Q2 2025 EarningsAugust 12, 2025 | finance.yahoo.comLucid Diagnostics (LUCD) Projected to Post Quarterly Earnings on WednesdayAugust 6, 2025 | marketbeat.comLucid Diagnostics to Participate in Upcoming Investor ConferencesAugust 5, 2025 | prnewswire.comLucid Diagnostics Inc. (NASDAQ:LUCD) Given Consensus Rating of "Buy" by AnalystsAugust 5, 2025 | marketbeat.comPAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025July 31, 2025 | prnewswire.comPAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleJuly 30, 2025 | finance.yahoo.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025July 30, 2025 | prnewswire.comLucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIGJuly 28, 2025 | msn.comSargent Investment Group LLC Sells 498,000 Shares of Lucid Diagnostics Inc. (NASDAQ:LUCD)July 21, 2025 | marketbeat.comLucid says meeting scheduled to determine Medicare coverage for cancer testJuly 16, 2025 | msn.comLucid Diagnostics' (LUCD) Buy Rating Reaffirmed at Needham & Company LLCJuly 16, 2025 | marketbeat.comMolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA TestJuly 16, 2025 | prnewswire.comLucid Diagnostics Inc News (LUCD) - Investing.comJuly 11, 2025 | investing.comLucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Buy" from AnalystsJuly 11, 2025 | marketbeat.com Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LUCD Media Mentions By Week LUCD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUCD News Sentiment▼0.460.76▲Average Medical News Sentiment LUCD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUCD Articles This Week▼63▲LUCD Articles Average Week Get the Latest News and Ratings for LUCD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Lucid Diagnostics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AVNS News ZIMV News KIDS News CBLL News SMLR News TMCI News DCTH News DRTS News NPCE News RXST News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUCD) was last updated on 10/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
